Open AccessPractical Advices About How To Handle Disease Progression During Osimertinib In EGFR-Mutant NSCLC Patients: Is It The Same Old Story? A Mini Review
Author(s) -
Alessio Cortellini,
Fiamma Buttitta,
Alessandra Marchetti,
Corrado Ficorella
Publication year - 2018
Publication title -
journal of molecular and genetic medicine
Language(s) - English
Resource type - Journals
ISSN - 1747-0862
DOI - 10.4172/1747-0862.1000338
Subject(s) - osimertinib , medicine , mutant , disease , bioinformatics , computational biology , oncology , biology , genetics , cancer , gene , epidermal growth factor receptor , erlotinib